ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

NCCR Calls For 15% Increase In NIH Budget, “Investment Priority”

February 11, 1994

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983